Status:
RECRUITING
Tunisian Registry of Trans Catheter Aortic Valve Implantation
Lead Sponsor:
Les Laboratoires des Médicaments Stériles
Collaborating Sponsors:
Tunisian Society of Cardiology and Cardiovascular Surgery
Conditions:
Tunisian Patients Already Implanted With a TAVI
Eligibility:
All Genders
18-85 years
Brief Summary
Transcatheter aortic valve implantation (TAVI) has emerged as a transformative therapy for patients with severe aortic stenosis, particularly those designated high-risk or inoperable for traditional s...
Eligibility Criteria
Inclusion
- \- Any Tunisian patient who was treated with TAVI implantation in Tunisia
Exclusion
- Patients who are not Tunisians
- Patients not agreeing to sign consent, witnesses not agreeing to sign consent (family member)
Key Trial Info
Start Date :
September 23 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06503965
Start Date
September 23 2023
End Date
December 31 2025
Last Update
November 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital militaire principal d'instruction de Tunis
Tunis, Tunisia